Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy

Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy

Purpose Cisplatin is commonly prescribed in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy. Acute kidney injury (AKI) is regarded as a common complication after HIPEC combined with cytoreductive surgery (CRS). However, post-HIPEC chronic kidney disease (CKD) is scarce an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chih-Chung Cheng, Hung-Chieh Yeh, Pei-Wen Su, Chien-Lin Ho, Sheng-Chi Chang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	International Journal of Hyperthermia
Subjects:	Hyperthermic intraperitoneal chemotherapy chronic kidney disease acute kidney injury parecoxib cisplatin
Online Access:	https://www.tandfonline.com/doi/10.1080/02656736.2024.2304250
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy analysis of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer: a retrospective study
by: Zhijie Gong, et al.
Published: (2025-01-01)

Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural carcinosis
by: Louis-Emmanuel Chriqui, et al.
Published: (2024-01-01)

Perspectives of pressurized intraperitoneal aerosol chemotherapy in terms of primary ovarian cancer with peritoneal carcinomatosis treatment
by: A. S. Dzasokhov, et al.
Published: (2023-03-01)

Safety assessment of preventive pressurized intraperitoneal aerosol chemotherapy in combined treatment of gastric cancer: preliminary results
by: N. Ya. Muratova, et al.
Published: (2024-03-01)

3-year experience of hyperthermic intravesical chemotherapy use in patients with high risk non-muscular-invasive bladder cancer
by: R.S. Chystiakov, et al.
Published: (2023-06-01)

Prediction of Cisplatin‐Induced Acute Kidney Injury Using an Interpretable Machine Learning Model and Electronic Medical Record Information
by: Kaori Ambe, et al.
Published: (2025-01-01)

INTRAPERITONEAL AEROSOL CHEMOTHERAPY UNDER PRESSURE (IACUP) – AN INNOVATIVE METHOD OF TREATMENT OF PATIENTS WITH PERITONEAL CARCINOMATOSIS
by: A. D. Kaprin, et al.
Published: (2016-06-01)

Mechanism of dexmedetomidine protection against cisplatin induced acute kidney injury in rats
by: Zeng-lu Zheng, et al.
Published: (2024-12-01)

Protective effect of Panax ginseng extract on cisplatin-induced AKI via downregulating cell death associated genes
by: Reza Alipanah-Moghadam, et al.
Published: (2025-01-01)

Oncological outcomes in non-seminomatous testicular tumors and residual mass after cisplatin-based chemotherapy
by: María A. Ocampo-Gómez, et al.
Published: (2024-04-01)

The effect of pressurized intraperitoneal aerosolized chemotherapy on the surgical treatment outcomes of ovarian cancer with peritoneal carcinomatosis
by: A. S. Dzasochov, et al.
Published: (2024-06-01)

Sepsis-Associated Acute Kidney Disease Incidence, Trajectory, and Outcomes
by: Hsiu-Yin Chiang, et al.
Published: (2025-03-01)

Effects of Repeated Cisplatin and Monosodium Glutamate on Visceral Sensitivity in Rats
by: Yolanda López-Tofiño, et al.
Published: (2024-12-01)

Chemotherapy plus therapeutic plasmapheresis with 4% human albumin solution in multiple myeloma patients with acute kidney injury: a prospective, open-label, proof-of-concept study
by: Tianzhi Wu, et al.
Published: (2024-12-01)

Exploring the efficacy of fluorouracil and platinum based chemotherapy in advanced hepatocellular carcinoma to bridge the treatment gap in resource limited settings
by: Se Jun Park, et al.
Published: (2025-01-01)

Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models
by: Marcelo Simonsen, et al.
Published: (2025-01-01)

Post-operative Analgesia with Intraperitoneal Bupivacaine Alone and with Dexmedetomidine Following Laparoscopic Cholecystectomy
by: Anees Ahmad, et al.
Published: (2025-01-01)

Intraperitoneal Steroid Therapy for Recurrent Malignant Ascites in Advanced Cancer Patients: A Case Series
by: Nashid Islam, et al.
Published: (2025-01-01)

The Hippo pathway promotes platinum-based chemotherapy by inhibiting MTF1-dependent heavy metal response
by: Hui Chen, et al.
Published: (2025-02-01)

Case report: Conservative treatment of an intraperitoneal bladder rupture
by: Noah J. Sandel, et al.
Published: (2025-03-01)

Hyperthermia and cisplatin combination therapy promotes caspase-8 accumulation and activation to enhance apoptosis and pyroptosis in cancer cells
by: Guanghui Zi, et al.
Published: (2024-12-01)

Alterations in DNA Damage Repair Genes Before and After Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
by: Ursula Lemberger, et al.
Published: (2025-01-01)

Comparing Cisplatin Dosing Schedules in Concurrent Chemoradiotherapy for Locally Advanced Head-and-Neck Cancer: A Comprehensive Review of Weekly Versus 3-Weekly Regimens
by: Oscar Chi-Yu Yang, et al.
Published: (2024-12-01)

Adult-onset Renal Neuroblastoma: Case Report and Literature Review
by: Yao-Ren Yang, et al.
Published: (2024-12-01)

Ganoboninketal C from Ganoderma boninense improves the efficacy of CDDP-based chemotherapy through inhibiting translesion DNA synthesis
by: Xiaolu Ma, et al.
Published: (2024-09-01)

Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy
by: Hege S. Haugnes, et al.
Published: (2025-01-01)

Considerations in assessing blood glucose in mice: coping with interferences of intraperitoneal injection, noise, fasting, housing and blood sampling
by: Si-Li Zheng, et al.
Published: (2024-12-01)

Quercetin attenuates cisplatin-induced fatigue through mechanisms associated with the regulation of the HPA axis and MCP-1 signaling
by: Cheng-Hung Chuang, et al.
Published: (2025-01-01)

Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
by: Yu-Ling Lin, et al.
Published: (2025-01-01)

Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy
by: Csilla Olah, et al.
Published: (2025-01-01)

Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis
by: Ning Jin, et al.
Published: (2025-03-01)

Lebanese Cannabis sativa L. extract protects from cisplatin-induced nephrotoxicity in mice by inhibiting podocytes apoptosis
by: Alia Khalil, et al.
Published: (2025-01-01)

Potential therapeutic effect of thymoquinone on cisplatin-induced hepatotoxicity in rats
by: Sercan Kaya, et al.
Published: (2024-03-01)

Intraperitoneal fipronil effects on liver histopathological, biochemistry and morphology in Caspian kutum, Rutilus frisii kutum (Kamenskii, 1901)
by: R. Alijani Ardeshir, et al.
Published: (2017-12-01)

Clinical advances in kidney autotransplantation: a review
by: Shengjie Lin, et al.
Published: (2025-02-01)

Plasma proteome fingerprint in kidney diseases
by: Kirill S. Nikolsky, et al.
Published: (2025-01-01)

The impact of creatine supplementation on the development of kidney disease – literature review
by: Mateusz Matczak, et al.
Published: (2025-02-01)

Hepatocyte Nuclear Factor 1 Beta Mutation-associated Newborn Onset of Glomerulocystic Kidney Disease: A Case Presentation
by: Nilüfer Göknar, et al.
Published: (2021-12-01)

Deferiprone ameliorates cisplatin induced peripheral neurotoxicity via ferritinophagy adjustment
by: Hanan Seddiek, et al.
Published: (2025-02-01)

Effect of Slit3 on kidney fibrosis in diabetic kidney disease rats
by: Huang Ming-fang, et al.
Published: (2025-01-01)